Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xerecept vs Dexamethasone for Peritumoral Brain Edema in Glioma
NCT00226668Phase 3Withdrawn
- Sponsor
- Celtic Pharma
- Start
- Jan 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in Peritumoral brain edema (PTBE) comparing hCRF + Dexamethasone with Placebo + Dexamethasone (2 arms). Primary endpoint: Proportion of Responders at 2 weeks. Planned start Jan 2006; status: withdrawn.
02
Drugs
corticotrophin-releasing hormone
03
Conditions
Peritumoral brain edema (PTBE)
Beyond the preview
Go deeper on NCT00226668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226668.